ID

14228

Description

Study of the Effect of SR57667B in Patients With Alzheimer's Disease; ODM derived from: https://clinicaltrials.gov/show/NCT00285025

Link

https://clinicaltrials.gov/show/NCT00285025

Keywords

Versions (1)
  1. 4/5/16 4/5/16 -
Uploaded on

April 5, 2016

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Alzheimer Disease NCT00285025

English

Eligibility Alzheimer Disease NCT00285025

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
male / female outpatients.
Description

gender outpatients

Data type

boolean

Alias
UMLS CUI [1,1]
C0079399
UMLS CUI [1,2]
C0029921
age > 50 years at screening.
Description

age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
dementia of alzheimer’s type (dsm-iv 290.0) according to dsm-iv criteria, probable ad according to nincds-adrda criteria, mini-mental state examination score > 12 and < 26.
Description

dementia of alzheimers type; mini mental state examination score

Data type

boolean

Alias
UMLS CUI [1]
C0236649
UMLS CUI [2]
C2960235
untreated or treated for a minimum of 6 months before randomization with a stable dose of the cholinesterase inhibitors
Description

therapy cholinesterase inhibitors

Data type

boolean

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C0008425
generally healthy and ambulatory or ambulatory-aided (i.e., walker or cane).
Description

Health Status; ambulatory status

Data type

boolean

Alias
UMLS CUI [1]
C0018759
UMLS CUI [2]
C1550332
presence of a reliable caregiver.
Description

caregiver

Data type

boolean

Alias
UMLS CUI [1]
C0085537
patient, identified caregiver and, if applicable, patient surrogate (primary relative, legal guardian, medical proxy) have given their informed written consent and are capable of following study procedures
Description

informed consent

Data type

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
any cause of dementia not due to alzheimer’s disease, delusions, delirium, psychosis, depression, or other significant psychiatric disorder.
Description

dementia; alzheimers disease; delusions; psychosis; depression; psychiatric disorder

Data type

boolean

Alias
UMLS CUI [1]
C0497327
UMLS CUI [2]
C0002395
UMLS CUI [3]
C0011253
UMLS CUI [4]
C0033975
UMLS CUI [5]
C0011570
UMLS CUI [6]
C0004936
treatment with any registered or putative cognitive enhancer or disease modifier other than donepezil, rivastigmine or galantamine.
Description

donepezil; rivastigmine; galantamine

Data type

boolean

Alias
UMLS CUI [1]
C0527316
UMLS CUI [2]
C0649350
UMLS CUI [3]
C0016967
females who are pregnant or breast-feeding. females of child bearing potential (premenopausal female biologically capable of becoming pregnant) must have a confirmed negative serum b–hcg pregnancy test at the screening visit, and must use an acceptable method of birth control.
Description

pregnancy; lactating; premenopausal; negative pregnancy test

Data type

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
UMLS CUI [3]
C0232969
UMLS CUI [4]
C0427780
severe or unstable cardiovascular, respiratory, renal, hematological, endocrinological, neurological or other somatic disease.
Description

comorbidity cardiovascular disease respiratory disease hematological disease

Data type

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C0007222
UMLS CUI [1,3]
C0035204
UMLS CUI [1,4]
C0018939
use of cyp3a4 strong inhibitors
Description

cyp3a4 inhibitor

Data type

boolean

Alias
UMLS CUI [1]
C3830624
evidence (detected by history, physical examination and / or laboratory / ecg tests) of any clinically significant or unstable medical disorder that could interfere with the subject's participation in the clinical trial; interfere with the absorption, metabolism or excretion of the study medication; or interfere with the evaluation of the study drug. alterations of laboratory tests or ecg findings of potential clinical significance.
Description

Compliance behavior Limited Comorbidity

Data type

boolean

Alias
UMLS CUI [1,1]
C1321605
UMLS CUI [1,2]
C0439801
UMLS CUI [1,3]
C0009488
Back to the top of the page

Similar models

Eligibility Alzheimer Disease NCT00285025

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
gender outpatients
Item
male / female outpatients.
boolean
C0079399 (UMLS CUI [1,1])
C0029921 (UMLS CUI [1,2])
age
Item
age > 50 years at screening.
boolean
C0001779 (UMLS CUI [1])
dementia of alzheimers type; mini mental state examination score
Item
dementia of alzheimer’s type (dsm-iv 290.0) according to dsm-iv criteria, probable ad according to nincds-adrda criteria, mini-mental state examination score > 12 and < 26.
boolean
C0236649 (UMLS CUI [1])
C2960235 (UMLS CUI [2])
therapy cholinesterase inhibitors
Item
untreated or treated for a minimum of 6 months before randomization with a stable dose of the cholinesterase inhibitors
boolean
C0087111 (UMLS CUI [1,1])
C0008425 (UMLS CUI [1,2])
Health Status; ambulatory status
Item
generally healthy and ambulatory or ambulatory-aided (i.e., walker or cane).
boolean
C0018759 (UMLS CUI [1])
C1550332 (UMLS CUI [2])
caregiver
Item
presence of a reliable caregiver.
boolean
C0085537 (UMLS CUI [1])
informed consent
Item
patient, identified caregiver and, if applicable, patient surrogate (primary relative, legal guardian, medical proxy) have given their informed written consent and are capable of following study procedures
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
dementia; alzheimers disease; delusions; psychosis; depression; psychiatric disorder
Item
any cause of dementia not due to alzheimer’s disease, delusions, delirium, psychosis, depression, or other significant psychiatric disorder.
boolean
C0497327 (UMLS CUI [1])
C0002395 (UMLS CUI [2])
C0011253 (UMLS CUI [3])
C0033975 (UMLS CUI [4])
C0011570 (UMLS CUI [5])
C0004936 (UMLS CUI [6])
donepezil; rivastigmine; galantamine
Item
treatment with any registered or putative cognitive enhancer or disease modifier other than donepezil, rivastigmine or galantamine.
boolean
C0527316 (UMLS CUI [1])
C0649350 (UMLS CUI [2])
C0016967 (UMLS CUI [3])
pregnancy; lactating; premenopausal; negative pregnancy test
Item
females who are pregnant or breast-feeding. females of child bearing potential (premenopausal female biologically capable of becoming pregnant) must have a confirmed negative serum b–hcg pregnancy test at the screening visit, and must use an acceptable method of birth control.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0232969 (UMLS CUI [3])
C0427780 (UMLS CUI [4])
comorbidity cardiovascular disease respiratory disease hematological disease
Item
severe or unstable cardiovascular, respiratory, renal, hematological, endocrinological, neurological or other somatic disease.
boolean
C0009488 (UMLS CUI [1,1])
C0007222 (UMLS CUI [1,2])
C0035204 (UMLS CUI [1,3])
C0018939 (UMLS CUI [1,4])
cyp3a4 inhibitor
Item
use of cyp3a4 strong inhibitors
boolean
C3830624 (UMLS CUI [1])
Compliance behavior Limited Comorbidity
Item
evidence (detected by history, physical examination and / or laboratory / ecg tests) of any clinically significant or unstable medical disorder that could interfere with the subject's participation in the clinical trial; interfere with the absorption, metabolism or excretion of the study medication; or interfere with the evaluation of the study drug. alterations of laboratory tests or ecg findings of potential clinical significance.
boolean
C1321605 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial